New hope for cancer patients: drug may fix Radiation-Induced low platelets
NCT ID NCT07128576
First seen Nov 01, 2025 · Last updated May 12, 2026 · Updated 30 times
Summary
This study tests a drug called romiplostim N01 in 60 adults with solid tumors (like lung or breast cancer) who have low platelets from radiation-based treatments. The goal is to see if it safely raises platelet counts within 2 weeks, reducing the need for transfusions. It is a phase 2 trial, not yet recruiting, and focuses on managing a side effect rather than curing the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.